Faculty profile

George Zhanel

Back to faculty

ProfessorUniversity of Manitoba

George Zhanel

Professor

Max Rady College of Medicine

University of Manitoba

Winnipeg, Manitoba, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
17 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2008.
Supervisor on 1 trainee award (1 CIHR), most recently in 2023.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

249

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Roles and appointments

Associate head

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Manitoba profile.

Latest papers

Invasive pneumococcal disease surveillance in Canada, 2023.
Canada communicable disease report = Releve des maladies transmissibles au Canada · 2026
Investigation of colistin-resistant non-human Acinetobacter seifertii isolates.
Microbiology spectrum · 2026
Treatment of asymptomatic bacteriuria during pregnancy: A risk-factor-based approach.
Journal of global antimicrobial resistance · 2026 · first author

All 26 publications

Latest funding

Understanding the Impact of drug use on the Microbiome and Sexually Transmitted and Blood-Borne Infections
CIHR · 2023 · Supervisor
$270,000
Development of aminoglycoside antimicrobials with novel or combined modes of action
CIHR · 2011 · Co-investigator
$382,825
Optimization and preclinical studies on amphiphilic aminoglycoside antimicrobials (AAAs)
CIHR · 2011 · Co-investigator
$160,000

All 6 grants and awards

26 publications.

Invasive pneumococcal disease surveillance in Canada, 2023.

Golden A, Griffith A, Lefebvre B, McGeer A, Tyrrell G, Kus J, Grant J, Minion J, Van Caeseele P, Desnoyers G, Haldane D, Yu Y, Ding X, Steven L, McFadzen J, Zhanel G, Primeau C, Martin I

Canada communicable disease report = Releve des maladies transmissibles au Canada20262 citationsOpen Access

DOI: 10.14745/ccdr.v52i0102a05 PMID: 41924395

Investigation of colistin-resistant non-human Acinetobacter seifertii isolates.

Sykes EME, Dang YC, White D, Mateo-Estrada V, Muzaleva A, Zhanel G, Dettman J, Chapados J, Gerdis S, Khan IUH, Castillo-Ramírez S, Kumar A

Microbiology spectrum2026Open Access

DOI: 10.1128/spectrum.02311-26 PMID: 42752203

Treatment of asymptomatic bacteriuria during pregnancy: A risk-factor-based approach.

Zhanel G, de Rossi P, Oliva C, Johansen TEB

Journal of global antimicrobial resistance2026First author

DOI: 10.1016/j.jgar.2025.11.010 PMID: 41274602

Prevalence of and risk factors for antimicrobial resistance in pneumococcal disease in southern Ontario during the PCV13 era.

Shigayeva A, Coleman BL, Golden AR, Martin I, Zhanel G, Adam H, Gold WL, Kandel C, Katz KC, Krajden S, Lovinsky R, Muller MP, Ostrowska K, Rau N, Ricciuto D, Richardson D, Vermeiren C, Faheem A, Farooqi L, Green K, Hassan K, Lefebvre M, Li AX, Malik N, Nayani S, Pejkovska M, Plevneshi A, Sultana A, Vikulova T, Zhong Z, McGeer A, Toronto Invasive Bacterial Diseases Network

Vaccine2026

DOI: 10.1016/j.vaccine.2026.128351 PMID: 41785682

The State of Antimicrobial Resistance of Gram-Negative Bacilli in Canada.

Li J, Walkty A, Lagacé-Wiens P, Karlowsky J, Zhanel G

Tropical medicine and infectious disease20253 citationsSenior authorOpen Access

DOI: 10.3390/tropicalmed10040115 PMID: 40278788

Amphiphilic nebramine analogs synergize with β-lactam/β-lactamase inhibitor combinations, including cefepime-taniborbactam and meropenem-xeruborbactam against metallo-β-lactamase-carrying Pseudomonas aeruginosa.

Lozeau C, Ramirez D, Ramirez D, Kumar G, Arora R, Zhanel G, Arthur G, Schweizer F

RSC medicinal chemistry2025Open Access

DOI: 10.1039/d5md00375j PMID: 40734664

Intravenous Fosfomycin for Difficult-to-Treat Infections: A Real-Life Multicentric Study in Italy.

Zerbato V, Sanson G, Fusaro L, Gerussi V, Sincovich S, Dellai F, Del Fabro G, Geremia N, Maurel C, Giacomazzi D, Biasinutto C, Di Girolamo FG, Scrivo G, Costantino V, Di Santolo M, Busetti M, Crocè LS, Giuliano S, Crapis M, Zhanel G, Tascini C, Luzzati R, Di Bella S

Antibiotics (Basel, Switzerland)2025

DOI: 10.3390/antibiotics14040401 PMID: 40298561

Phylogenomic and phenotypic analyses highlight the diversity of antibiotic resistance and virulence in both human and non-human Acinetobacter baumannii.

Sykes EME, Mateo-Estrada V, Engelberg R, Muzaleva A, Zhanel G, Dettman J, Chapados J, Gerdis S, Akineden Ö, Khan IUH, Castillo-Ramírez S, Kumar A

mSphere202417 citationsOpen Access

DOI: 10.1128/msphere.00741-23 PMID: 38440986

Real-life experience with IV dalbavancin in Canada; results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry

Zhanel G, Silverman M, Malhotra J, Baxter M, Rahimi R, Irfan N, Girouard G, Dhami R, Kucey M, Stankus V

Journal of Global Antimicrobial Resistance202411 citationsFirst authorOpen Access

DOI: 10.1016/j.jgar.2024.06.002

Characterization of a colistin resistant, hypervirulent hospital isolate of Acinetobacter courvalinii from Canada.

Sykes EME, Mateo-Estrada V, Muzaleva A, Zhanel G, Dettman J, Chapados J, Gerdis S, Akineden Ö, Castillo-Ramírez S, Khan IUH, Kumar A

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology20245 citations

DOI: 10.1007/s10096-024-04873-0 PMID: 39073669

Understanding the Impact of drug use on the Microbiome and Sexually Transmitted and Blood-Borne Infections

SupervisorCIHR2023CIHR REDI Early Career Transition Award - HIV/AIDS and STBBI

Principal investigators: Herrera Diaz, Mariana D

Keywords: Drug Use; Hiv Treatment; Hiv/Aids; Human Immunodeficiency Virus; Microbiome; People Living With Hiv; People Who Are Experiencing Houselesness; Sex Workers; Sexually Transmitted And Blood Borne Infections

$270,000

Development of aminoglycoside antimicrobials with novel or combined modes of action

Co-investigatorCIHR2011Operating Grant

Principal investigators: Schweizer, Frank

Keywords: Aminoglycosides; Antibacterials; Drug Discovery; Resistance

$382,825

Optimization and preclinical studies on amphiphilic aminoglycoside antimicrobials (AAAs)

Co-investigatorCIHR2011Proof of Principle Program - Phase I

Principal investigators: Schweizer, Frank

Keywords: Aminoglycosides; Antibiotics; Cationic Amphiphiles; Drug Discovery; Medicinal Chemistry

$160,000

Antibiotic Resistance Research Pipeline

Co-investigatorCIHR2009Canada-UK Joint Health Research Program on Antibiotic Resistance

Principal investigators: Wright, Gerard D

Keywords: Antibiotic Resistance; Database; Mechanisms; Surveillance

$60,000

Preclinical evaluation of aminoglycoside antibiotics-derived amphiphiles (AADAs)

Co-investigatorCIHR2009CIHR/Regional Partnership Program/Operating Grants

Principal investigators: Schweizer, Frank

Keywords: Aminoglycosides; Antibacterials; Bacterial Resistance; Infectious Diseases; Medicinal Chemistry; Pharmaceuticals

$103,472

Preclinical evaluation of antimicrobial ultrashort aminoglycoside- peptide conjugates

Principal investigatorCIHR2008Proof of Principle Program - Phase I

Principal investigators: Schweizer, Frank; Zhanel, George G

Keywords: Antibacterial Therapeutics; Bacterial Resistance; Cationic Glycoconjugates; Combinatorial Chemistry; Infectious Diseases; Multi-Drug Resistant Antibacterial Susceptibility

$150,000

From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

George Zhanel

Research

Latest papers

Latest funding

Invasive pneumococcal disease surveillance in Canada, 2023.

Investigation of colistin-resistant non-human Acinetobacter seifertii isolates.

Treatment of asymptomatic bacteriuria during pregnancy: A risk-factor-based approach.

Prevalence of and risk factors for antimicrobial resistance in pneumococcal disease in southern Ontario during the PCV13 era.

The State of Antimicrobial Resistance of Gram-Negative Bacilli in Canada.

Amphiphilic nebramine analogs synergize with &#x3b2;-lactam/&#x3b2;-lactamase inhibitor combinations, including cefepime-taniborbactam and meropenem-xeruborbactam against metallo-&#x3b2;-lactamase-carrying Pseudomonas aeruginosa.

Intravenous Fosfomycin for Difficult-to-Treat Infections: A Real-Life Multicentric Study in Italy.

Phylogenomic and phenotypic analyses highlight the diversity of antibiotic resistance and virulence in both human and non-human Acinetobacter baumannii.

Real-life experience with IV dalbavancin in Canada; results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry

Characterization of a colistin resistant, hypervirulent hospital isolate of Acinetobacter courvalinii from Canada.

Understanding the Impact of drug use on the Microbiome and Sexually Transmitted and Blood-Borne Infections

Development of aminoglycoside antimicrobials with novel or combined modes of action

Optimization and preclinical studies on amphiphilic aminoglycoside antimicrobials (AAAs)

Antibiotic Resistance Research Pipeline

Preclinical evaluation of aminoglycoside antibiotics-derived amphiphiles (AADAs)

Preclinical evaluation of antimicrobial ultrashort aminoglycoside- peptide conjugates

Frequent collaborators

Ayush Kumar

Frank Schweizer

James Karlowsky

Allison McGeer

Andrew Walkty

Neal Irfan

Gregory Tyrrell

Philippe Lagacé-Wiens

Julianne Kus

J. Nickel

Sigmund Krajden

Christopher Kandel

Karl Weiss

Sheryl Zelenitsky

Andrew McIvor

Song Liu

Christopher Mody

Joshua Kimani

Jennifer Grant

Michael Silverman

Heather Adam

Mark Loeb

Amphiphilic nebramine analogs synergize with β-lactam/β-lactamase inhibitor combinations, including cefepime-taniborbactam and meropenem-xeruborbactam against metallo-β-lactamase-carrying Pseudomonas aeruginosa.